Using intermittent theta burst stimulation to maintain depression treatment
Official title: Intermittent Theta Burst Stimulation for Maintenance Therapy in Depression
Run by University of Regensburg · NCT05732311 · Data updated 2026-11-12
This study is testing whether giving people with depression who have benefited from a specific brain stimulation treatment either once a week or all at once can help them stay feeling better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | University of Regensburg Academic / other |
| Locations | 1 site (Regensburg) |
| Status | Recruiting |
| Started | April 25, 2023 |
| Main results expected | January 31, 2026 |
| Study ends | February 28, 2026 |
| Registry record updated | December 1, 2025 |
| Trial ID | NCT05732311 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 70 with a diagnosis of a depressive episode, recurrent depressive disorder, or bipolar disorder who have responded positively to prior iTBS treatment.
✕Probably not a fit
Patients with severe neurological diseases or those with contraindications for TMS, such as electrical implants, will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study involves a randomized, multi-center, open-label approach where patients with depression who previously responded to intermittent theta burst stimulation (iTBS) will receive this treatment as maintenance therapy. Participants will be divided into two groups based on the frequency of stimulation: one group will receive standard iTBS over a week, while the other will receive accelerated iTBS in one day. An interim analysis will be conducted after half of the patients have been treated to estimate the effect size.
Why it matters
Potential benefit: If successful, this approach could provide a novel maintenance therapy option for patients with depression, potentially improving their long-term outcomes.
How similar studies have gone: While the use of iTBS has shown promise in treating depression, this specific approach as maintenance therapy is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * adult women and men aged 18 to 70 years with an ICD-10 diagnosis of a depressive episode of depressive disorder (F32), recurrent depressive disorder (F33), or bipolar disorder (F31) * moderate or severe current episode prior to initial open iTBS treatment (HAMD-21 \>16 points) * response to iTBS treatment (either reduction in HAMD score by 50% or score at the end of treatment \<11 points) * no concomitant psychotic symptoms. * no other relevant psychiatric disorder as assessed by the study physician * residence in Germany and German speaking that allows understanding of the information provided * patient is capable of giving consent Exclusion Criteria: * fulfillment of the general contraindications for TMS (electrical implants or metallic objects in the body such as pacemakers or insulin pumps). * severe neurological diseases (e.g., cerebrovascular events, neurodegenerative diseases, epilepsy, malformations of the brain, severe head injury in the history) * current harmful use or dependence on alcohol, amphetamines, cocaine, benzodiazepines, anticonvulsants, or opiates * acute suicidality * pregnancy * current participation in another study
Where it's running
-
Department of Psychiatry and Psychotherapy, University of Regensburg
Regensburg, Germany Recruiting
Study contacts
- Principal investigator: Berthold Langguth, Prof. — University Hospital of Regensburg, Department of Psychiatry and Psychotherapy at the Bezirksklinikum
- Study coordinator: Martin Schecklmann, Prof.
- Email: martin.schecklmann@medbo.de
- Phone: +49-941-941-2054
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Smartphone-supported single-session psychotherapy for postpartum depression
A single online therapy session plus four weeks of app-based support is being tested to see if it reduces depressive symptoms in postpartum women compared with a waitlist.
-
Mindful Smartphone Use: A Mindfulness-Based Program for Teens with Sleep and Mood Challenges
This study tests Mindwire, a mindfulness-based program, to see if it helps teens with problematic phone use who also have depression or anxiety.
-
Tele-based wellbeing centres for women's mental health in Bangladesh
A randomized trial tests whether tele-counselling for depression and anxiety in Bangladeshi women is as effective as in-person counselling.
-
Remote monitoring for adults with depression using ThIA Suivi
This study tests whether adding the ThIA Suivi remote monitoring tool to usual psychiatric care helps adults with depression feel more improved after 3 months compared with standard care alone.
-
HBOT to see if it helps cognition and well‑being in first responders with prior brain injury
This study tests whether 40 hyperbaric oxygen therapy sessions can improve thinking skills and post-concussion symptoms in current or former first responders with a history of brain injury.
-
Focused ultrasound for mood and anxiety disorders
This study tests whether repeated low-intensity focused ultrasound using the ATTN201 device can help people with subsyndromal to moderate depression, anxiety, or OCD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.